Bio-Rad Laboratories Inc (BIO)
279.83
+0.52
(+0.19%)
USD |
NYSE |
May 03, 16:00
280.08
+0.25
(+0.09%)
Pre-Market: 20:00
Bio-Rad Laboratories Total Assets (Quarterly): 12.30B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 12.30B |
September 30, 2023 | 11.90B |
June 30, 2023 | 11.98B |
March 31, 2023 | 13.67B |
December 31, 2022 | 13.50B |
September 30, 2022 | 12.06B |
June 30, 2022 | 12.68B |
March 31, 2022 | 14.37B |
December 31, 2021 | 17.80B |
September 30, 2021 | 19.95B |
June 30, 2021 | 15.12B |
March 31, 2021 | 13.93B |
December 31, 2020 | 12.97B |
September 30, 2020 | 12.02B |
June 30, 2020 | 10.10B |
March 31, 2020 | 8.684B |
December 31, 2019 | 8.009B |
September 30, 2019 | 7.177B |
June 30, 2019 | 7.647B |
March 31, 2019 | 6.863B |
December 31, 2018 | 5.611B |
September 30, 2018 | 6.719B |
June 30, 2018 | 6.386B |
March 31, 2018 | 6.215B |
December 31, 2017 | 4.273B |
Date | Value |
---|---|
September 30, 2017 | 4.186B |
June 30, 2017 | 4.143B |
March 31, 2017 | 3.953B |
December 31, 2016 | 3.851B |
September 30, 2016 | 4.020B |
June 30, 2016 | 3.875B |
March 31, 2016 | 3.753B |
December 31, 2015 | 3.710B |
September 30, 2015 | 3.666B |
June 30, 2015 | 3.525B |
March 31, 2015 | 3.326B |
December 31, 2014 | 3.341B |
September 30, 2014 | 3.386B |
June 30, 2014 | 3.468B |
March 31, 2014 | 3.441B |
December 31, 2013 | 3.389B |
September 30, 2013 | 3.280B |
June 30, 2013 | 3.483B |
March 31, 2013 | 3.457B |
December 31, 2012 | 3.444B |
September 30, 2012 | 3.303B |
June 30, 2012 | 3.169B |
March 31, 2012 | 3.188B |
December 31, 2011 | 3.097B |
September 30, 2011 | 2.970B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.177B
Minimum
Sep 2019
19.95B
Maximum
Sep 2021
12.41B
Average
12.30B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
Agilent Technologies Inc | 10.95B |
Bruker Corp | 4.506B |
Azenta Inc | 2.824B |
Harvard Bioscience Inc | 137.37M |
Bionano Genomics Inc | 214.40M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.558B |
Shareholders Equity (Quarterly) | 8.741B |
Debt to Equity Ratio | 0.1372 |
Current Ratio | 5.831 |
Net Debt Paydown Yield | -0.03% |